Reviewed by FDA against compounding inclusion in December 2024
A study of patients with non-alcoholic fatty liver disease (NAFLD) revealed that giving 300 mg of glutathione daily for four months resulted in significant reductions in elevated ALT (an enzyme associated with liver damage), triglycerides, and ferritin
While GHK-Cu works systemically, rotating injections near problem areas (around the abdomen, upper arms, or thighs) can provide both systemic and localized benefits simultaneously
They added BPC-157 to Category 2 of substances presenting significant safety risks, noting concerns about immune reactions, peptide impurities, and lack of safety data for any human use
Improved Recovery: If you exercise, you might notice that you feel less "run down" the day after a hard workout